ViV-TAVR in patients with small aortic annuli was associated with a higher risk of prosthesis-patient mismatch compared to nonsmall annuli (59.2% vs 44.4%; OR 1.9, 95% CI 1.26-2.87; P=0.002).
Observational (n=405)
Yes
Does Valve-in-Valve TAVR in patients with small aortic annuli increase the risk of prosthesis-patient mismatch or adverse clinical outcomes compared to those with nonsmall annuli?
405 Japanese patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) for failed surgical bioprosthetic aortic valves, derived from the J-TVT registry.
ViV-TAVR in patients with small aortic annuli (defined as an aortic annulus area of ≤314 mm² measured using preoperative computed tomography).
ViV-TAVR in patients with nonsmall aortic annuli (>314 mm²).
Composite end point evaluated at 30 days and 1 year (components not specified in abstract) and prosthesis-patient mismatch (PPM, defined as indexed effective orifice area <0.85 cm²/m² assessed using echocardiography within 30 days).composite
In Japanese patients undergoing ViV-TAVR, small aortic annuli increase the risk of prosthesis-patient mismatch but do not significantly impact 30-day or 1-year clinical outcomes.
Effect estimate: OR 1.9 (95% CI 1.26-2.87)
Absolute Event Rate: 59.2% vs 44.4%
p-value: p=0.002
BACKGROUND: Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) provides an alternative treatment for high-risk patients with failed surgical bioprosthetic aortic valves. However, limited data exist on ViV-TAVR outcomes in patients with small aortic annuli, particularly among the relatively small-statured Japanese population. METHODS: We analyzed data from the J-TVT (Japan Transcatheter Valve Therapy) registry, which included all TAVR institutions across Japan, with data collected from July 2018, when ViV-TAVR was approved, through December 2022. A small aortic annulus was defined as an aortic annulus area of ≤314 mm², measured using preoperative computed tomography for ViV-TAVR. Prosthesis-patient mismatch (PPM) was defined as an indexed effective orifice area <0.85 cm²/m², assessed using echocardiography within 30 days after ViV-TAVR. The composite end point was evaluated at 30 days and 1 year. RESULTS: Among 47 800 individuals, 1029 underwent ViV-TAVR, resulting in a final sample of 405 patients. The mean indexed effective orifice area was 0.83 cm²/m² in the small annulus group (n=225) and 0.94 cm²/m² in the nonsmall group (n=180), with PPM rates of 59.2% and 44.4%, respectively. Small annuli were independently associated with PPM (odds ratio, 1.9 95% CI, 1.26–2.87; P =0.002). No differences in 30-day and 1-year outcomes were observed between groups. Among the 225 patients with small annuli, the mean indexed effective orifice area was 0.76 cm 2 /m 2 in the balloon-expandable valve group (n=61) and 0.86 cm 2 /m 2 in the supraannular self-expanding valve group (n=164), with PPM rates of 67.2% and 56.1%, respectively. No differences in outcomes were noted based on the type of valve implanted. CONCLUSIONS: ViV-TAVR for small aortic annuli in Japanese patients was associated with an increased risk of PPM; however, no differences in clinical outcomes were observed according to aortic annulus size or valve type. Due to the small size of our sample, further research is required to validate these findings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yusuke Oba
Obayashi (Japan)
Hiraku Kumamaru
Kyorin University
Satoshi Hoshide
Preventive Cardiology
Circulation Cardiovascular Interventions
The University of Osaka
Keio University
Yokohama City University
Building similarity graph...
Analyzing shared references across papers
Loading...
Oba et al. (Wed,) conducted a observational in Failed surgical bioprosthetic aortic valves (n=405). ViV-TAVR in small aortic annuli (≤314 mm²) vs. ViV-TAVR in nonsmall aortic annuli (>314 mm²) was evaluated on Prosthesis-patient mismatch (PPM) (OR 1.9, 95% CI 1.26-2.87, p=0.002). ViV-TAVR in patients with small aortic annuli was associated with a higher risk of prosthesis-patient mismatch compared to nonsmall annuli (59.2% vs 44.4%; OR 1.9, 95% CI 1.26-2.87; P=0.002).
synapsesocial.com/papers/6a09061b29af591ab701724f — DOI: https://doi.org/10.1161/circinterventions.124.015087